Patient Characteristics, n=55
Gender, n (%)
Male 33 (60)
Female 22 (40)
Solid organ, n (%)
Heart 28 (51)
Kidney 9 (16)
Multivisceral 7 (13)
Liver 6 (11)
Lung 5 (9)
Immunosuppression, n (%) ≥ 2 agents including tacrolimus ≥ 2 agents no tacrolimus Tacrolimus only Cyclosporine only Disease Characteristics, n=55 Sub-type, n (%) DLBCL Burkitt lymphoma NK/T cell lymphoma Other Stage, n (%) 31 (56) 1 (2) 21 (38) 2 (4) 23 (42) 25 (45) 5 (9) 2 (4)
I II III IV Unknown/incomplete staging EBER positive, n (%) 4 (7) 8 (15) 31 (56) 10 (18) 2 (4)
Yes No 35 (64) 17 (31)
Unknown First line treatment, n (%) RIS Rituximab with chemotherapy Ritiximab without chemotherapy Chemotherapy LMB-96 Cyclophosphamide & prednisone Other 3 (5) 49 (89) 40 (73) 4 (7) 46 (84) 22 (40) 14 (26) 10 (18)